Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | Cipla Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases. | |
Founding Date | Founding Date 1978 | Founding Date 1985 | Founding Date 1935 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Mumbai, IN HQ South Melbourne, AU Mumbai, IN Nairobi, KE Cape Town, ZA Durban, ZA Durban, ZA see more |
Employees | Employees 7,57013% decrease | Employees 8,920 | Employees 27,7644% increase |
Valuation ($) | Valuation ($) 27.5 b | Valuation ($) 4.6 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $9.8b (FY, 2023) | Revenue (est.) ¥12.2b (FY, 2023) | Revenue (est.) ₹254.5b (FY, 2024) |
Cost of goods | Cost of goods $2.5b (FY, 2023) | Cost of goods ¥4.5b (FY, 2023) | Cost of goods ₹88.2b (FY, 2024) |
Gross profit | Gross profit $7.3b (FY, 2023) | Gross profit ¥7.8b (FY, 2023) | Gross profit ₹169.5b (FY, 2024) |
Net income | Net income $1.2b (FY, 2023) | Net income ¥1.9b (FY, 2023) | Net income ₹41.6b (FY, 2024) |